A detailed history of Blair William & CO transactions in Veru Inc. stock. As of the latest transaction made, Blair William & CO holds 350,000 shares of VERU stock, worth $248,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350,000
Previous 350,000 -0.0%
Holding current value
$248,500
Previous $294,000 8.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.76 - $1.79 $15,200 - $35,800
20,000 Added 6.06%
350,000 $294,000
Q3 2023

Nov 09, 2023

BUY
$0.72 - $1.33 $7,200 - $13,300
10,000 Added 3.13%
330,000 $237,000
Q2 2023

Aug 11, 2023

BUY
$0.98 - $1.49 $19,516 - $29,673
19,915 Added 6.64%
320,000 $380,000
Q4 2022

Feb 10, 2023

SELL
$4.78 - $15.01 $191,200 - $600,400
-40,000 Reduced 11.76%
300,085 $1.58 Million
Q2 2022

Aug 10, 2022

BUY
$4.35 - $15.85 $44,196 - $161,036
10,160 Added 3.08%
340,085 $3.84 Million
Q1 2022

May 13, 2022

BUY
$4.55 - $6.41 $68,250 - $96,150
15,000 Added 4.76%
329,925 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $29,744 - $49,136
5,050 Added 1.63%
314,925 $1.86 Million
Q3 2021

Nov 12, 2021

SELL
$6.78 - $9.89 $339 - $494
-50 Reduced 0.02%
309,875 $2.64 Million
Q2 2021

Aug 12, 2021

BUY
$7.24 - $11.2 $36,200 - $56,000
5,000 Added 1.64%
309,925 $2.5 Million
Q1 2021

May 13, 2021

BUY
$8.05 - $20.78 $40,250 - $103,900
5,000 Added 1.67%
304,925 $3.29 Million
Q4 2020

Feb 09, 2021

BUY
$2.36 - $9.99 $406,628 - $1.72 Million
172,300 Added 135.0%
299,925 $2.59 Million
Q2 2019

Aug 13, 2019

BUY
$1.26 - $2.14 $63,000 - $107,000
50,000 Added 64.41%
127,625 $272,000
Q1 2019

May 14, 2019

BUY
$1.2 - $1.59 $6,000 - $7,950
5,000 Added 6.88%
77,625 $113,000
Q4 2018

Feb 14, 2019

SELL
$1.21 - $1.54 $111,562 - $141,988
-92,200 Reduced 55.94%
72,625 $102,000
Q2 2018

Aug 13, 2018

BUY
$1.64 - $2.29 $270,313 - $377,449
164,825 New
164,825 $333,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.